Evaluating the Efficacy and Effectiveness of Long Acting Injectables Versus Oral Antipsychotics in the Treatment of Schizophrenia


Date: Jun 19, 2020 01:30 PM - 02:30 PM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on Aug 14, 2020 11:55 AM

Activity Type

Knowledge

Target Audience(s)

Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

Registration Closed  

Objectives

  • Describe the clinical manifestations of schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders 5th Edition (DSM5)
  • Explain the pharmacological treatment approach for schizophrenia and identify the differences in tolerability of typical and atypical antipsychotic
  • Identify the clinical factors and patient preferences that influence the prescribing of different antipsychotic formulations
  • Interpret the clinical trial outcomes of studies regarding the use of long acting injectables versus oral antipsychotics in schizophrenia therapy

Speaker(s)/Author(s)

Jessica Pinchinat, PharmD, RPh

Activity Number

0010-0000-20-019-L01-P
Date: 06/19/20
Time: 01:30 PM - 02:30 PM

CE Hours

1.00
Registration Closed